Swiss National Bank Axonics, Inc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Axonics, Inc. stock. As of the latest transaction made, Swiss National Bank holds 99,600 shares of AXNX stock, worth $7.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

99,600

Previous 100,300 0.7%

Holding current value

$7.07 Million

Previous $6.74 Million 2.91%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$67.3 - $69.67 $47,110 - $48,769	-700 Reduced 0.7%	99,600 $6.94 Million
Q2 2024 Aug 08, 2024	BUY	$66.47 - $69.65 $19,941 - $20,895	300 Added 0.3%	100,300 $6.74 Million
Q1 2024 May 07, 2024	BUY	$56.67 - $69.36 $34,002 - $41,616	600 Added 0.6%	100,000 $6.9 Million
Q4 2023 Feb 06, 2024	SELL	$49.38 - $63.75 $557,994 - $720,375	-11,300 Reduced 10.21%	99,400 $6.19 Million
Q3 2023 Nov 08, 2023	BUY	$48.64 - $62.51 $97,280 - $125,020	2,000 Added 1.84%	110,700 $6.21 Million
Q2 2023 Aug 09, 2023	BUY	$47.99 - $60.21 $1.11 Million - $1.4 Million	23,200 Added 27.13%	108,700 $5.49 Million
Q1 2023 May 10, 2023	SELL	$52.6 - $67.34 $468,140 - $599,326	-8,900 Reduced 9.43%	85,500 $4.66 Million
Q4 2022 Feb 08, 2023	BUY	$59.56 - $76.6 $303,756 - $390,660	5,100 Added 5.71%	94,400 $5.9 Million
Q3 2022 Nov 09, 2022	BUY	$57.96 - $78.12 $115,920 - $156,240	2,000 Added 2.29%	89,300 $6.29 Million
Q2 2022 Aug 09, 2022	BUY	$39.5 - $64.42 $201,450 - $328,542	5,100 Added 6.2%	87,300 $4.95 Million
Q1 2022 May 09, 2022	BUY	$43.74 - $62.76 $262,440 - $376,560	6,000 Added 7.87%	82,200 $5.15 Million
Q4 2021 Feb 08, 2022	BUY	$50.01 - $73.35 $45,009 - $66,015	900 Added 1.2%	76,200 $4.27 Million
Q3 2021 Nov 08, 2021	BUY	$59.21 - $78.66 $550,653 - $731,538	9,300 Added 14.09%	75,300 $4.9 Million
Q2 2021 Aug 06, 2021	BUY	$51.39 - $66.9 $822,240 - $1.07 Million	16,000 Added 32.0%	66,000 $4.19 Million
Q1 2021 May 07, 2021	BUY	$49.14 - $59.89 $44,226 - $53,901	900 Added 1.83%	50,000 $3 Million
Q4 2020 Feb 05, 2021	BUY	$42.19 - $51.5 $46,409 - $56,650	1,100 Added 2.29%	49,100 $2.45 Million
Q3 2020 Nov 09, 2020	BUY	$35.33 - $51.04 $24,731 - $35,728	700 Added 1.48%	48,000 $2.45 Million
Q2 2020 Aug 05, 2020	BUY	$22.91 - $39.83 $348,232 - $605,416	15,200 Added 47.35%	47,300 $1.66 Million
Q1 2020 May 08, 2020	BUY	$16.44 - $37.73 $4,932 - $11,318	300 Added 0.94%	32,100 $816,000
Q4 2019 Feb 06, 2020	BUY	$19.57 - $28.96 $258,324 - $382,272	13,200 Added 70.97%	31,800 $881,000
Q3 2019 Nov 12, 2019	BUY	$26.92 - $42.41 $13,460 - $21,205	500 Added 2.76%	18,600 $501,000
Q2 2019 Aug 02, 2019	BUY	$18.54 - $40.97 $335,574 - $741,557	18,100 New	18,100 $742,000

Others Institutions Holding AXNX

# of Institutions

234

Shares Held

42.1M

Call Options Held

83.4K

Put Options Held

65.3K

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Axonics, Inc. Transaction History